178 related articles for article (PubMed ID: 11037554)
1. Permanent source brachytherapy for prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Potters L; Perez CA; Beyer DC; Blasko JC; Forman JD; Hussey DH; Lee WR; Paryani SB; Pollack A; Roach M; Scardino P; Schellhammer P; Leibel S
Radiology; 2000 Jun; 215 Suppl():1383-400. PubMed ID: 11037554
[No Abstract] [Full Text] [Related]
2. Node-positive prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Lee WR; Pollack A; Perez CA; Beyer DC; Blasko JC; Forman JD; Hussey DH; Paryani SB; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
Radiology; 2000 Jun; 215 Suppl():1413-8. PubMed ID: 11037556
[No Abstract] [Full Text] [Related]
3. Locally advanced (high-risk) prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Pollack A; Paryani SB; Hussey D; Perez CA; Beyer DC; Blasko JC; Forman JD; Lee WR; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
Radiology; 2000 Jun; 215 Suppl():1401-12. PubMed ID: 11037555
[No Abstract] [Full Text] [Related]
4. Postradical prostatectomy irradiation in carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
Perez CA; Beyer DC; Blasko JC; Forman JD; Hussey DH; Lee WR; Paryani SB; Pollack A; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
Radiology; 2000 Jun; 215 Suppl():1419-39. PubMed ID: 11037557
[No Abstract] [Full Text] [Related]
5. Editorial comment.
Lee WR
Urology; 2010 Jun; 75(6):1416-7; author reply 1417. PubMed ID: 20513503
[No Abstract] [Full Text] [Related]
6. Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
Perez CA; Beyer DC; Blasko JC; Forman JD; Hussey DH; Lee WR; Paryani SB; Pollack A; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
Radiology; 2000 Jun; 215 Suppl():1449-72. PubMed ID: 11037559
[No Abstract] [Full Text] [Related]
7. Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Roach M; Blasko JC; Perez CA; Beyer DC; Forman JD; Hussey DH; Lee WR; Paryani SB; Pollack A; Potters L; Scardino P; Schellhammer P; Leibel S
Radiology; 2000 Jun; 215 Suppl():1441-8. PubMed ID: 11037558
[No Abstract] [Full Text] [Related]
8. Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Adamovich E
Urology; 2004 Oct; 64(4):754-9. PubMed ID: 15491715
[TBL] [Abstract][Full Text] [Related]
9. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH; Allen Z; Adamovich E
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):32-43. PubMed ID: 15629591
[TBL] [Abstract][Full Text] [Related]
10. Anal cancer. American College of Radiology. ACR Appropriateness Criteria.
John MJ; Merrick GS; Coia LR; Minsky BD; Bader JL; Janjan NA; Raben D; Rich TA; Rosenthal SA; Tepper JE; Ota D; Saltz L; Leibel S
Radiology; 2000 Jun; 215 Suppl():1501-11. PubMed ID: 11037563
[No Abstract] [Full Text] [Related]
11. [Brachytherapy for localised prostate cancer].
Peiffert D
Cancer Radiother; 2007 Nov; 11(6-7):373-8. PubMed ID: 17962060
[TBL] [Abstract][Full Text] [Related]
12. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer.
Morris WJ; Keyes M; Palma D; Spadinger I; McKenzie MR; Agranovich A; Pickles T; Liu M; Kwan W; Wu J; Berthelet E; Pai H
Urology; 2009 Apr; 73(4):860-5; discussion 865-7. PubMed ID: 19168203
[TBL] [Abstract][Full Text] [Related]
13. Impact of brachytherapy on regional, racial, marital status, and age-related patterns of definitive treatment for clinically localized prostate carcinoma.
Copeland LA; Elshaikh MA; Jackson J; Penner LA; Underwood W
Cancer; 2005 Oct; 104(7):1372-80. PubMed ID: 16118801
[TBL] [Abstract][Full Text] [Related]
14. The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy.
Potters L; Huang D; Fearn P; Kattan MW
Brachytherapy; 2003; 2(1):26-31. PubMed ID: 15062160
[TBL] [Abstract][Full Text] [Related]
15. [Radiotherapy of prostate cancer].
Knüfermann H; Wannenmacher M
Urologe A; 1986 Jan; 25(1):18-22. PubMed ID: 3962039
[TBL] [Abstract][Full Text] [Related]
16. [Initial experiences with iodine-121 implantation in 41 patients with prostatic carcinoma].
Battermann JJ; Boon TA; Beijert M; de Voogt HJ
Ned Tijdschr Geneeskd; 1987 Sep; 131(36):1573-6. PubMed ID: 3670438
[No Abstract] [Full Text] [Related]
17. Monotherapeutic brachytherapy for clinically organ-confined prostate cancer.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Adamovich E
W V Med J; 2005; 101(4):168-71. PubMed ID: 16296198
[TBL] [Abstract][Full Text] [Related]
18. [Low dose brachytherapy with seeds--an interdisciplinary therapy alternative to radical prostatectomy].
Kahmann F; Henkel T
Praxis (Bern 1994); 2001 Sep; 90(36):1523-31. PubMed ID: 11593908
[TBL] [Abstract][Full Text] [Related]
19. Prostate carcinoma: curative radiotherapy.
Knüfermann H; Wannenmacher M
Bull Cancer; 1985; 72(6):568-72. PubMed ID: 4092106
[TBL] [Abstract][Full Text] [Related]
20. Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: a review of the H. Lee Moffitt Cancer Center experience.
Torres-Roca JF; Cantor AB; Shukla S; Montejo ME; Friedland J; Seigne JD; Heysek R; Pow-Sang J
Urol Oncol; 2006; 24(5):384-90. PubMed ID: 16962486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
